LEADER 02568nam 2200565 a 450 001 9910785115503321 005 20230828215644.0 010 $a1-282-80173-2 010 $a9786612801730 010 $a1-4416-6139-5 010 $a93-5043-529-2 010 $a600-00-2715-X 035 $a(CKB)2670000000047479 035 $a(EBL)588365 035 $a(OCoLC)700692367 035 $a(SSID)ssj0000672353 035 $a(PQKBManifestationID)11415321 035 $a(PQKBTitleCode)TC0000672353 035 $a(PQKBWorkID)10635189 035 $a(PQKB)10381738 035 $a(MiAaPQ)EBC588365 035 $a(Au-PeEL)EBL588365 035 $a(CaPaEBR)ebr10416258 035 $a(EXLCZ)992670000000047479 100 $a20101015d2006 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aBiopharmaceuticals$b[electronic resource] /$fS.N. Jogdand 205 $a1st ed. 210 $aMumbai [India] $cHimalaya Pub. House$d2006 215 $a1 online resource (283 p.) 300 $aDescription based upon print version of record. 311 $a81-8318-620-3 320 $aIncludes bibliographical references and index. 327 $aCOVER; CONTENTS; INTRODUCTION; MARKET FOR BIOPHARMACEUTICALS; BIOPHARMACEUTICAL INDUSTRY; BIOPHARMACEUTICAL SECTOR IN INDIA; DRUG DISCOVERY AND DRUG DESIGNING; PHARMACOKINETICS; CLINICAL TRIALS; REGULATORY; THERAPEUTIC PROTEINS; BLOOD PRODUCTS; MONOCLONAL ANTIBODIES; HORMONE THERAPY; VACCINE PRODUCTION-NEW DEVELOPMENTS; TRANSGENIC PRODUCTION OF BIOPHARMACEUTICALS; HUMAN GENE THERAPY; ANTISENSE TECHNOLOGY (DNA MEDICINES) 330 $aBiopharmaceuticals are complex macromolecules created through the genetic manipulation of living organisms using gene cloning, recombinant DNA(gene splicing), or fusion technologies. Although small molecule drugs remain the standard treatment for disease, new strategies based on the engineering of proteins, genes and cell as therapeutic agents will revolutionize medicine in the coming decades. More than 20 percent of new medicines launched in 2003 were produced using biotechnology, nearly 80 percent of those under development either use use of biotechnology or are derived from it. The biopharm 606 $aBiopharmaceutics 615 0$aBiopharmaceutics. 676 $a615/.7 700 $aJogdand$b S. N$01478028 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910785115503321 996 $aBiopharmaceuticals$93725726 997 $aUNINA LEADER 02173nam 2200457 450 001 9910825114703321 005 20230807214829.0 010 $a2-335-05460-0 035 $a(CKB)3790000000022926 035 $a(EBL)2085412 035 $a(MiAaPQ)EBC2085412 035 $a(Au-PeEL)EBL2085412 035 $a(OCoLC)914152225 035 $a(EXLCZ)993790000000022926 100 $a20200120d2015 uy 0 101 0 $afre 135 $aur|n|---||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 13$aLa migration des oiseaux /$fA. de Brevans 210 1$a[Place of publication not identified] :$cLigaran,$d2015. 215 $a1 online resource (248 p.) 300 $aDescription based upon print version of record. 327 $aCouverture; Page de Copyright; Page de titre; CHAPITRE PREMIER - Introduction; CHAPITRE II - Migration ge?ne?rale; CHAPITRE III - Migrateurs du Sud-Est; CHAPITRE VI - Migrateurs du Sud-Ouest; CHAPITRE V - Migrateurs du Sud; CHAPITRE VI - Migrateurs accidentels; CHAPITRE VII - Conclusions 330 $a Extrait : ""Ce n'est pas des moindres curiosite?s ou des moindres merveilles de la nature que la translation bisannuelle du monde des oiseaux des contre?es du Nord vers celle du Midi, et de celles-ci vers les premie?res. Certaines espe?ces parmi les quadrupe?des, les poissons et les insectes, sont aussi soumises a? des migrations...""A? PROPOS DES E?DITIONS LIGARANLes e?ditions LIGARAN proposent des versions nume?riques de qualite? de grands livres de la litte?rature classique mais e?galement des livres rares en partenariat avec la BNF. Beaucoup de soins sont apporte?s a? ces versions ebook pour e?viter les 606 $aAnimal behavior 606 $aBirds$xMigration 606 $aMigratory birds 615 0$aAnimal behavior. 615 0$aBirds$xMigration. 615 0$aMigratory birds. 676 $a636.70887 700 $aBrevans$b A. de$01712166 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910825114703321 996 $aLa migration des oiseaux$94104085 997 $aUNINA